Menu Search
Equities

Myomo Inc

MYO:ASQ

Myomo Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)4.81
  • Today's Change-0.21 / -4.18%
  • Shares traded328.53k
  • 1 Year change+154.50%
  • Beta1.6379
Data delayed at least 15 minutes, as of Nov 09 2024 01:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Myomo Inc grew revenues 23.70% from 15.56m to 19.24m while net income improved from a loss of 10.72m to a smaller loss of 8.15m.
Gross margin70.03%
Net profit margin-33.22%
Operating margin-33.26%
Return on assets-50.25%
Return on equity-82.54%
Return on investment-81.40%
More ▼

Cash flow in USDView more

In 2023, Myomo Inc increased its cash reserves by 28.53%, or 1.53m. Cash Flow from Financing totalled 9.71m or 50.48% of revenues. In addition the company used 6.17m for operations while cash used for investing totalled 2.03m.
Cash flow per share-0.2236
Price/Cash flow per share--
Book value per share0.3072
Tangible book value per share0.3072
More ▼

Balance sheet in USDView more

Myomo Inc has a strong Balance Sheet and has consistently grown its cash reserves over the last Four years to total 6.87m.
Current ratio2.10
Quick ratio1.62
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.